News and Insights

Managing Globally and Locally

India’s Developing Market Offers Opportunities

BioPharm International

Recognizing that emerging markets continue to play a significant role in terms of future growth, most major pharmaceutical companies have accelerated efforts to strengthen their presence within these markets through R&D investment, licensing deals, acquisitions, or other partnerships.  However, with global markets facing dynamic demographic and disease trends, changing market…

Navigating Emerging Markets — Israel

BioPharm International

The Middle East has been rocked in recent years by upheaval. While the potential for disruption is real, the region has been characterized as well by rapid growth in the healthcare sector. One of its brightest lights is Israel. It is a developed, industrialized nation that, despite ongoing conflict with…

Changing Payer Perspectives on Market Access Across the G-5

eyeforpharma

It was less than a decade ago that most pharmaceutical manufacturers considered market access the last step in the commercialization process… maybe even something that happened post-launch! However it has become increasingly clear that this approach must change. Companies exploring opportunities in global markets face dynamic demographic and disease trends,…

Navigating Emerging Markets — Middle East and North Africa

BioPharm International

The Middle East and North Africa have been rocked in recent years by upheaval ranging from moderate protest to full-scale revolution, leading to a variety of changes in government, and more changes to come.  Still, medical products companies such as GE Healthcare have described the region as its “hidden jewel,”…

Navigating Emerging Markets – South Korea

BioPharm International

South Korea is a rapidly growing pharmaceutical market. Previously considered a developing economy, this country was reclassified as a developed economy in 2010, though it is still considered an emerging market. In recent years, South Korea’s high growth rate has continued amid worldwide economic downturns and is expected to continue…

Navigating Emerging Markets – Southeast Asia

BioPharm International

Southeast Asia is a growing pharmaceutical market. Much like Latin America, the countries of southeast Asia, especially the members of the Association of Southeast Asian Nations (ASEAN: Brunei, Burma, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, and Vietnam), have taken initial steps towards seeking more harmonized regulation of pharmaceutical…